Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CELF2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PKI55 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
MYCN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CARS2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
YPEL5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CYB5B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UBE2V2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
H2AFV - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GADD45A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SKAP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BICD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TXNL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LRP11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM14C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HOXA5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C21orf2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CA8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM86B3P - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DYNLRB1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ABRACL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on